New COVID booster tested on teens shows promise
NCT ID NCT06234956
Summary
This study tested a COVID-19 booster vaccine called BIMERVAX in teenagers aged 12 to 18. Researchers wanted to see if it was safe and how well it boosted the immune system in teens who had already received two Pfizer shots. They followed 242 participants for a year, checking for side effects and measuring antibody levels against different virus variants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CAP Centelles
Centelles, Barcelona, 08540, Spain
-
CAP Peralada
Peralada, Girona, 17491, Spain
-
Hospial HM Montepríncipe
Boadilla del Monte, Madrid, 28660, Spain
-
Hospital HM Puerta del Sur
Móstoles, Madrid, 28938, Spain
-
Hospital Josep Trueta
Girona, Girona, 17007, Spain
-
Hospital La Paz
Madrid, Madrid, 28046, Spain
-
Hospital Vall Hebron
Barcelona, Barcelona, 08035, Spain
Conditions
Explore the condition pages connected to this study.